Feasibility and Clinical Activity of Initial Intraperitoneal Catumaxomab Followed by Chemotherapy in Patients With Recurrent Ovarian Cancer
Clinical trial NCT01815528 · COMPLETED
Trial details
- NCT number
- NCT01815528
- Sponsor
- JSehouli
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-02-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.